MIR6769A

Across TCGA pan-cancer cohorts, MIR6769A RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR6769A’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR6769A RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6769A is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

KIRC, LUSC, and THCA are the cancer types where MIR6769A tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6769A RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.275	.001	5	view →
LUSC	Female	All	−0.702	.017	2	view →
THCA	Female	II,III,IV	−0.530	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR6769A–KIRC

Open the KIRC breakdown →